New Delhi: National Pharmaceutical Pricing Authority (NPPA) has issued notices to leading drug making companies for failing to register their products on its online database and submit the mandatory disclosures. NPPA has taken a serious view of disobedience of the Drug Pricing Control Order (DPCO) by the companies.
The authority plans to issue notices to other firms as well that have not furnished information so far. “We have issued notices to top 10 firms that have not registered their products under IPDMS and will also be issuing notices to others,” NPPA Chairman Bhupendra Singh said on Monday.
NPPA had asked all pharma firms to register themselves with the Integrated Pharmaceutical Database Management System (IPDMS) in September 2014. The authority has issued many price notifications, especially during March-June 2016, but many pharma companies have not submitted the forms as required, NPPA said in a notice on its website.
“In this regard, NPPA is now constrained to issue show-cause notices to individual companies,” it said, adding, “NPPA shall also be constrained to take necessary legal action against the companies including prosecution under the EC Act under unavoidable circumstances.”
NPPA had asked all pharmaceutical firms to register under IPDMS for online filing of returns for monitoring, fixing and revision of drug prices.